QuickView for Plectin (biogroup)

1. Breast cancer MCF7 cells with EIF4A1 siRNA knockdown - total, polysomal & subpolysomal RNA fractions
2. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
3. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
5. Embryonic kidney HEK293 cells expressing DDX3 wildtype or variant R534H treated with sodium arsenite

There were no matches for Plectin

1. Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
2. Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bu…
3. Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
4. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibod…